Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Published:2014-09 Issue:10 Volume:15 Page:1100-1108
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Stupp Roger,Hegi Monika E,Gorlia Thierry,Erridge Sara C,Perry James,Hong Yong-Kil,Aldape Kenneth D,Lhermitte Benoit,Pietsch Torsten,Grujicic Danica,Steinbach Joachim Peter,Wick Wolfgang,Tarnawski Rafał,Nam Do-Hyun,Hau Peter,Weyerbrock Astrid,Taphoorn Martin J B,Shen Chiung-Chyi,Rao Nalini,Thurzo László,Herrlinger Ulrich,Gupta Tejpal,Kortmann Rolf-Dieter,Adamska Krystyna,McBain Catherine,Brandes Alba A,Tonn Joerg Christian,Schnell Oliver,Wiegel Thomas,Kim Chae-Yong,Nabors Louis Burt,Reardon David A,van den Bent Martin J,Hicking Christine,Markivskyy Andriy,Picard Martin,Weller Michael

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009;Dolecek;Neuro-Oncol,2012

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Glioblastoma survival in the United States before and during the temozolomide era;Johnson;J Neuro Oncol,2012

4. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial;Gilbert;J Clin Oncol,2013

5. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma;Weller;Lancet Oncol,2014

Cited by 824 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the biophysical landscape: how physical cues steer the journey of bone metastatic tumor cells;Trends in Cancer;2024-09

2. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

3. Integrins in cancer stem cells;Frontiers in Cell and Developmental Biology;2024-08-21

4. The Proangiogenic Effects of Melanoma-Derived Ectosomes Are Mediated by αvβ5 Integrin Rather than αvβ3 Integrin;Cells;2024-08-12

5. A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine;Nature Communications;2024-08-11